Chemoinformaics analysis of Tetrahydroactinidiolide
| Molecular Weight | 182.263 | nRot | 0 |
| Heavy Atom Molecular Weight | 164.119 | nRig | 11 |
| Exact Molecular Weight | 182.131 | nRing | 2 |
| Solubility: LogS | -3.878 | nHRing | 1 |
| Solubility: LogP | 3.145 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 31.9763 |
| nHD | 0 | BPOL | 20.6617 |
| QED | 0.538 |
| Synth | 3.612 |
| Natural Product Likeliness | 3.096 |
| NR-PPAR-gamma | 0.025 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.371 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.619 |
| MDCK | 0.0000256 |
| BBB | 0.842 |
| PPB | 0.77342 |
| VDSS | 0.681 |
| FU | 0.506119 |
| CYP1A2-inh | 0.066 |
| CYP1A2-sub | 0.375 |
| CYP2c19-inh | 0.185 |
| CYP2c19-sub | 0.879 |
| CYP2c9-inh | 0.137 |
| CYP2c9-sub | 0.328 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.539 |
| CYP3a4-inh | 0.065 |
| CYP3a4-sub | 0.285 |
| CL | 11.065 |
| T12 | 0.435 |
| hERG | 0.01 |
| Ames | 0.012 |
| ROA | 0.045 |
| SkinSen | 0.618 |
| Carcinogencity | 0.204 |
| EI | 0.898 |
| Respiratory | 0.857 |
| NR-Aromatase | 0.019 |
| Antiviral | No |
| Prediction | 0.817566 |